Document Detail


Assessment of response to systemic therapy focusing on metastatic bone disease.
MedLine Citation:
PMID:  11417968     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The 25-year-old rules for response evaluation developed by UICC and WHO still remain the cornerstone for response evaluation and documentation of treatment effects from systemic cancer treatment. Often, however, plain radiographs are insensitive to changes in tumour growth and disagree with clinical findings. Other methods of evaluation, such as biochemical markers and newer imaging technology may provide valuable additional information in these cases.
Authors:
C Blomqvist
Related Documents :
23068708 - Locally recurrent prostate cancer after initial radiation therapy: early salvage high-i...
10773538 - 18f-labeled radiopharmaceuticals for pet in oncology, excluding fdg.
12458398 - Lean body mass-based standardized uptake value, derived from a predictive equation, mig...
12190138 - The superficial mandibular gland of the rabbit: a new experimental model for scintigrap...
3299078 - Effect of histamine h2-receptor antagonist therapy on the mutagenic activity of gastric...
17160068 - Health-related quality-of-life after external beam radiation therapy for localized pros...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cancer treatment reviews     Volume:  27     ISSN:  0305-7372     ISO Abbreviation:  Cancer Treat. Rev.     Publication Date:  2001 Jun 
Date Detail:
Created Date:  2001-06-21     Completed Date:  2001-07-05     Revised Date:  2009-11-17    
Medline Journal Info:
Nlm Unique ID:  7502030     Medline TA:  Cancer Treat Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  177-80     Citation Subset:  IM    
Copyright Information:
Copyright 2001 Harcourt Publishers Ltd.
Affiliation:
Department of Radiotherapy and Oncology, Helsinki, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers
Bone Neoplasms / secondary*,  therapy*
Bone and Bones / radionuclide imaging
Humans
Magnetic Resonance Imaging
Tomography, X-Ray Computed
Chemical
Reg. No./Substance:
0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Metastatic bone disease: clinical features, pathophysiology and treatment strategies.
Next Document:  Bone markers in the management of metastatic bone disease.